Furuichi Kengo, Shimizu Miho, Okada Hirokazu, Narita Ichiei, Wada Takashi
Kengo Furuichi, Division of Nephrology, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Department of Nephrology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-cho, Irumagun, Saitama, 350-0451, Japan.
Clin Exp Nephrol. 2018 Oct;22(5):1046-1051. doi: 10.1007/s10157-018-1556-4. Epub 2018 Mar 21.
Diabetic kidney disease is the major cause of end-stage kidney disease in developed countries. However, the onset of kidney disorder and the progression pattern of kidney dysfunction and proteinuria greatly vary cases by cases. Therefore, risk classification with clinical data and pathological findings is important. Recent clinico-pathological study with kidney biopsy samples from diabetic patients revealed that pathological changes of diabetic nephropathy are characteristic and have special impacts on prognosis in each clinical stage. Moreover, comparison of the clinico-pathological findings of diabetic nephropathy with hypertensive nephrosclerosis revealed that there are few differences in their pathological findings in cases with low albuminuria and preserved estimated glomerular filtration rate (eGFR). Because it is so difficult to clearly distinguish pure kidney lesions caused by diabetes and kidney lesions due to effects other than diabetes, it is vital that these overlapped pathological findings be confirmed on kidney biopsy in cases of early stage diabetes. Further research is warranted regarding the pathogenesis of diabetic nephropathy and indication of kidney biopsy in diabetic cases.
糖尿病肾病是发达国家终末期肾病的主要原因。然而,肾脏疾病的发病以及肾功能障碍和蛋白尿的进展模式在不同病例中差异很大。因此,利用临床数据和病理结果进行风险分类很重要。最近对糖尿病患者肾脏活检样本进行的临床病理研究表明,糖尿病肾病的病理变化具有特征性,并且在每个临床阶段对预后都有特殊影响。此外,糖尿病肾病与高血压肾硬化的临床病理结果比较显示,在低蛋白尿和估算肾小球滤过率(eGFR)保留的病例中,它们的病理结果差异不大。由于很难明确区分由糖尿病引起的单纯肾脏病变和由糖尿病以外的其他因素导致的肾脏病变,因此在糖尿病早期病例中,通过肾脏活检确认这些重叠的病理结果至关重要。关于糖尿病肾病的发病机制以及糖尿病病例中肾脏活检的指征,有必要进行进一步研究。